Population Pharmacokinetics of Tenofovir (TFV) and Tenofovir Diphosphate (TFVdp) in the Blood, Semen, and Mononuclear Cells of HIV-Negative and Positive Men Receiving Tenofovir Disoproxil Fumarate (TDF) or Tenofovir Alafenamide (TAF)

被引：0
|
作者：
Greene, Stephen A. [1 ,2 ]
Chen, Jingxian [1 ,2 ]
Prince, Heather [3 ]
Maas, Brian [1 ,2 ]
Maffuid, Kaitlyn [1 ,2 ]
Garrett, Katy [1 ,2 ]
Sykes, Craig [1 ,2 ]
Schauer, Amanda [1 ,2 ]
Gay, Cynthia L. [3 ]
Kashuba, Angela D. M. [1 ,2 ,3 ]
Cohen, Myron S. [3 ]
Dumond, Julie B. [1 ,2 ]
机构：
[1] UNC, Eshelman Sch Pharm, Chapel Hill, NC USA
[2] UNC, Sch Med, Chapel Hill, NC USA
[3] Univ N Carolina, Chapel Hill, NC USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-037
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
    De Clercq, Erik
    [J]. BIOCHEMICAL PHARMACOLOGY, 2016, 119 : 1 - 7
  • [2] Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
    Kawuma, Aida N.
    Wasmann, Roeland E.
    Sinxadi, Phumla
    Sokhela, Simiso M.
    Chandiwana, Nomathemba
    Venter, Willem D. F.
    Wiesner, Lubbe
    Maartens, Gary
    Denti, Paolo
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2023, 12 (06): : 821 - 830
  • [3] Safety of tenofovir alafenamide (TAF) in patients with a history of proximal renal tubulopathy on tenofovir disoproxil fumarate (TDF)
    Hamzah, L.
    Jones, R.
    Bailey, A.
    Williams, D.
    Johnson, M.
    Ibrahim, F.
    Musso, C.
    Burling, K.
    Campbell, L.
    Post, F.
    [J]. HIV MEDICINE, 2019, 20 : 8 - 9
  • [4] Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study
    Lok, James
    Veloz, Maria Fernanda Guerra
    Byrne, Ruth
    Carey, Ivana
    Childs, Kate
    Agarwal, Kosh
    Nelson, Mark
    [J]. CLINICAL THERAPEUTICS, 2024, 46 (02) : 159 - 163
  • [5] Minimal Changes in Urine Markers of Tubular Dysfunction in CHB Patients Receiving Tenofovir alafenamide (TAF) compared with Tenofovir Disoproxil Fumarate (TDF)
    Lim, Young-Suk
    Ide, Tatsuya
    Strasser, Simone I.
    Yoon, Ki Tae
    Paik, Seung Woon
    Flaherty, John F.
    Kim, Kyungpil
    Gaggar, Anuj
    Subramanian, Mani
    Mangia, Alessandra
    Simon, Krzysztof
    Kwan, Peter
    Gane, Edward J.
    [J]. HEPATOLOGY, 2016, 64 : 940A - 940A
  • [6] Tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) switches: real-world observation of impact on lipid profiles
    Banks, T.
    Ashton, K.
    Ustianowski, A.
    Uriel, A.
    [J]. HIV MEDICINE, 2020, 21 : 56 - 57
  • [7] The Lymphoid Tissue Pharmacokinetics of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide in HIV-Infected Persons
    Fletcher, Courtney V.
    Podany, Anthony T.
    Thorkelson, Ann
    Winchester, Lee C.
    Mykris, Timothy
    Anderson, Jodi
    Jorstad, Siri
    Baker, Jason V.
    Schacker, Timothy W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 108 (05) : 971 - 975
  • [8] The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile
    Squillace, Nicola
    Ricci, Elena
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Passerini, Simone
    Martinelli, Canio
    Mameli, Maria Sabrina
    Maggi, Paolo
    Falasca, Katia
    Cordier, Laura
    Celesia, Benedetto Maurizio
    Salomoni, Elena
    Di Biagio, Antonio
    Pellicano, Giovanni Francesco
    Bonfanti, Paolo
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 5515 - 5520
  • [9] Eligibility of patients in a community HIV setting for switching rilpivirine/emtricitabine/tenofovir disoproxil fumarate (R/F/TDF) to tenofovir alafenamide(TAF)
    Goorney, B.
    Perez, K.
    [J]. HIV MEDICINE, 2019, 20 : 39 - 39
  • [10] Population Modeling Highlights Drug Disposition Differences Between Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate in the Blood and Semen
    Greene, Stephen A.
    Chen, Jingxian
    Prince, Heather M. A.
    Sykes, Craig
    Schauer, Amanda P.
    Blake, Kimberly
    Nelson, Julie A. E.
    Gay, Cynthia L.
    Cohen, Myron S.
    Dumond, Julie B.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (04) : 821 - 830
12345